Bernard Mandrand
55Patents
15h-index
70Co-inventors
87Inventor score
Filing activity: Mar 16, 1993 → May 3, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5824517A | Method for amplifying nucleic acid sequences by strand displacement using DNA/RNA chimeric primers | Chemistry; Metallurgy | 154 | Expired |
| US5695926A | Sandwich hybridization assays using very short capture probes noncovalently bound to a hydrophobic support | Chemistry; Metallurgy | 73 | Expired |
| US6342396B1 | Method for isolating, in particular for detecting or quantifying an analyte in a medium | Emerging Cross-Sectional Technologies | 69 | Expired |
| US6133047A | Superparamagnetic monodisperse particles | Emerging Cross-Sectional Technologies | 65 | Expired |
| US6994314B2 | Valves activated by electrically active polymers or by shape-memory materials, device containing same and method for using same | Mechanical Engineering; Lighting; Heating | 59 | Expired |
| US7217457B2 | Composite particles, derived conjugates, preparation method and applications | Emerging Cross-Sectional Technologies | 50 | Expired |
| US7001589B2 | Composite nanospheres and their conjugates with biomolecules | Emerging Cross-Sectional Technologies | 37 | Expired |
| US6866838B1 | Composite nanospheres and their conjugates with biomolecules | Emerging Cross-Sectional Technologies | 36 | Expired |
| US5510084A | Process for immobilizing a nucleic acid fragment by passive attachment to a solid substrate, the solid substrate thus obtained, and its use | Emerging Cross-Sectional Technologies | 36 | Expired |
| US5988197A | Freeze valve and treatment enclosure controlled by at least one such valve | Emerging Cross-Sectional Technologies | 31 | Expired |
| US5695936A | Reagent and method for the detection of a nucleotide sequence with signal amplification | Chemistry; Metallurgy | 31 | Expired |
| US6521341B1 | Magnetic particles, method for obtaining same and uses for separating molecules | Emerging Cross-Sectional Technologies | 29 | Expired |
| US5723344A | Device for the capture of target molecules, and capturing process using the device | Emerging Cross-Sectional Technologies | 27 | Expired |
| US6270953A | Method for detecting and/or quantifying a gliotoxic factor | Physics | 20 | Expired |
| US5654143A | RNA amplification method requiring only one manipulation step | Chemistry; Metallurgy | 16 | Expired |
| US6001987A | Isolated nucleotide sequences associated with Multiple sclerosis | Chemistry; Metallurgy | 15 | Expired |
| US6342383B1 | Cell lines and viral isolates associated with multiple sclerosis | Emerging Cross-Sectional Technologies | 12 | Expired |
| US5489653A | Water-soluble compounds derived from homopolymer or copolymer of maleic anhydride, and applications of the said compounds to supporting biological molecules | Emerging Cross-Sectional Technologies | 11 | Expired |
| US5800980A | Detection of MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, by nucleic acid hybridization | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6017707A | Reagent and method for the detection of a nucleotide sequence with signal amplification | Chemistry; Metallurgy | 8 | Expired |
| US5976789A | System of probes enabling HLA-DR typing to be performed, and typing method using said probes | Chemistry; Metallurgy | 8 | Expired |
| US6033853A | Nucleotide sequence detection with signal amplification | Chemistry; Metallurgy | 8 | Expired |
| US5876954A | Cytotoxic factor as is associated with multiple sclerosis, its detection and its quantification | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5902746A | Assembly for treating a sample in a liquid medium, in particular a biological material | Chemistry; Metallurgy | 6 | Expired |
| US5439972A | Water-soluble compounds derived from a homopolymer or copolymer of maleic anhydride, and applications of the said compounds to supporting biological molecules | Emerging Cross-Sectional Technologies | 5 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.